CactoHealth

Prevention of chronic lymphedema
– a major side-effect from breast cancer treatment

Lymphedema is a TOP 3 concern for breast cancer survivors ​

+ 50 Mio.

breast cancer survivors – globally

Survival rate of breast cancer

90% and >75% after 10 years

+ 20%

breast cancer survivors – globally

“Enabling early treatment for halting lymphedema development has a significant Impact on the lives of millions of breast cancer survivors”​
- Ida
“During breast cancer treatment I was followed closely, received a tailored treatment plan and guidance. But as breast cancer survivor there is no established support system to help me live with the risk of developing lymphedema and other side-effects from treatment. Staying in control of my situation is top of my mind”
- Patient

Early detection and prevention of chronic lymphedema ​ - the new normal.​

Cacto Health is building MyLymphCare, the first at-home monitoring solution for breast cancer–related lymphedema.​

Today, too many breast cancer survivors face lifelong complications and stigma because lymphedema is detected late. ​

Reshaping the use of traditional bioimpedance spectroscopy, we empower women to detect fluid changes early, track their recovery, and stay in control of their health.​

“By shifting monitoring from the hospital to the home, we are enabling women to stay active, independent, and reassured — while helping healthcare systems reduce cost and burden. ​

Our mission is to put prevention at the center of women’s health. “​

Ida Grønborg, CEO Cacto Health

​

Who is/The team behind Cacto Health?

Chief Executive Officer​
Ida Grønborg​
PhD, Researcher
Chief Technology Officer​
Mads Skak ​
M.Sc. Industrial Design
Regulatory Affairs/Quality Assurance specialist​
Greta Butkus​
Medical Doctor
Commercial & Marketing​
Anders Kryger​
MBA & Founder of Chromaviso
University Professor.
Tine Damsgaard​
Hospital South Denmark, Odense and Vejle Hospitals

If you want to learn more, please reach out!

If you are a breast cancer survivor​

If you are a Health Professional ​

If you are an investor ​

Get in touch with us

Keep up with us for updates at

LinkedIn